ArticleCerebellum (London, England)2026
Targeting Cognitive Dysfunction in Spinocerebellar Ataxia Type 2 Through Digital Cognitive Training.
Article in Cerebellum (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Spinocerebellar ataxia type 2 (SCA2) is a neurodegenerative disorder characterized not only by motor impairment but also by significant cognitive decline. While cognitive training programs have shown promising results in other neurological conditions, evidence regarding their efficacy in SCA2 remains scarce. Objective: To assess cognitive performance in patients with SCA2 and to evaluate the impact of a digital cognitive training program on cognitive functions. Methods: Twelve SCA2 patients (50% male; 46 ± 11.51 years old; 8 ± 3.69 years of education) underwent a comprehensive neuropsychological assessment before and after a six-month cognitive training program delivered through the NeuroNation® digital platform. The evaluated cognitive functions included memory, executive function, language, complex attention, and perceptual–motor abilities. A control group of 12 healthy individuals from the community was selected and matched for sex, age, and education (50% male; 47 ± 11.68 years old; 8 ± 3.85 years of education). Results: SCA2 patients exhibited significantly lower performance across multiple cognitive functions compared to controls, with marked impairments in verbal and visual memory, verbal fluency, attention, and executive function. Following the intervention, significant improvements were observed in several memory subcomponents, including incidental, immediate, delayed, and recognition memory. However, changes in executive functions were limited or absent. No strong correlations were found between game difficulty level and neuropsychological test outcomes. Conclusion: SCA2 patients demonstrated significant cognitive impairments, particularly in memory-related functions, and responded to digital cognitive training. These findings suggest the potential role of targeted interventions in supporting cognitive function in SCA2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.